Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Dec;12(6):976-990.
doi: 10.1007/s12975-021-00887-4. Epub 2021 Jan 26.

Immune Cell Infiltration into the Brain After Ischemic Stroke in Humans Compared to Mice and Rats: a Systematic Review and Meta-Analysis

Carolin Beuker #  1 , Jan-Kolja Strecker #  1 , Rajesh Rawal  2 , Antje Schmidt-Pogoda  1 , Tobias Ruck  1 , Heinz Wiendl  1 , Luisa Klotz  1 , Wolf-Rüdiger Schäbitz  3 , Clemens J Sommer  4 , Heike Minnerup  2 , Sven G Meuth  1 , Jens Minnerup  5
Affiliations
Meta-Analysis

Immune Cell Infiltration into the Brain After Ischemic Stroke in Humans Compared to Mice and Rats: a Systematic Review and Meta-Analysis

Carolin Beuker et al. Transl Stroke Res. 2021 Dec.

Abstract

Although several studies have suggested that anti-inflammatory strategies reduce secondary infarct growth in animal stroke models, clinical studies have not yet demonstrated a clear benefit of immune modulation in patients. Potential reasons include systematic differences of post-ischemic neuroinflammation between humans and rodents. We here performed a systematic review and meta-analysis to summarize and compare the spatial and temporal distribution of immune cell infiltration in human and rodent stroke. Data on spatiotemporal distribution of immune cells (T cells, macrophages, and neutrophils) and infarct volume were extracted. Data from all rodent studies were pooled by means of a random-effect meta-analysis. Overall, 20 human and 188 rodent stroke studies were included in our analyses. In both patients and rodents, the infiltration of macrophages and neutrophils preceded the lymphocytic influx. Macrophages and neutrophils were the predominant immune cells within 72 h after infarction. Although highly heterogeneously across studies, the temporal profile of the poststroke immune response was comparable between patients and rodents. In rodent stroke, the extent of the immune cell infiltration depended on the duration and location of vessel occlusion and on the species. The density of infiltrating immune cells correlated with the infarct volume. In summary, we provide the first systematic analysis and comparison of human and rodent post-ischemic neuroinflammation. Our data suggest that the inflammatory response in rodent stroke models is comparable to that in patients with stroke. However, the overall heterogeneity of the post-ischemic immune response might contribute to the translational failure in stroke research.

Keywords: Immune cell infiltration; Inflammation; Ischemic stroke; Meta-analysis.

PubMed Disclaimer

Conflict of interest statement

HW: honoraria for Scientific Advisory Boards Biogen, Evgen, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Roche Pharma AG, and Sanofi-Aventis. Speaker honoraria and travel support from Alexion, Biogen, Cognomed, F. Hoffmann-La Roche Ltd., Gemeinnützige Hertie-Stiftung, Merck Serono, Novartis, Roche Pharma AG, Genzyme, TEVA, and WebMD Global. Paid consultant for Abbvie, Actelion, Biogen, IGES, Johnson & Johnson, Novartis, Roche, Sanofi-Aventis, and the Swiss Multiple Sclerosis Society. Research is funded by RE Children’s Foundation, Biogen, GlaxoSmithKline GmbH, Roche Pharma AG, Sanofi-Genzyme.

LK: Compensation for Scientific Advisory Boards for Alexion, Genzyme, Janssen, Merck Serono, Novartis and Roche. Speaker honoraria and travel support from Bayer, Biogen, Genzyme, Grifols, Merck Serono, Novartis, Roche, Santhera and Teva. Research support from Biogen, Novartis and Merck Serono.

CJS and WRS are inventors on the patent application “Hematopoietic factors for treatment of neurological condition” including stroke. Recently a part of the application (ALS) was granted. CJS and WRS transferred their rights to Sygnis and received a minor financial compensation upfront. In case of efficacy CJS and WRS participate in form of royalties. WRS: Compensation as PI of the AXIS I study.

SM: Speaker honoraria and travel support from Almirall, Amicus Therapeutics Germany, Bayer Health Care, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS und Teva. Research is funded by Almirall, Amicus Therapeutics Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, HERZ Burgdorf, Merck Serono, Novartis, ONO Pharma, Roche, and Teva.

JM: Grants from EVER Pharma Jena GmbH, and Ferrer International, travel grants from Boehringer Ingelheim, and speaking fees from Bayer Vital and Chugai Pharma.

CB, RR, JKS, ASP, HM, and TR declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Temporal and quantitative characterization of immune cell infiltration in rodent stroke at days 1–7 after induction of ischemia. Flow cytometric analysis of the ipsilateral brain hemisphere (a) and histological analysis (b infarct core, c penumbra) showing the absolute numbers (bare circles) of infiltrating immune cells (macrophages, neutrophils, and T cells) in the ischemic hemisphere in rats (blue) and mice (green). Meta-analyzed data are shown as mean with higher and lower 95% confidence interval. In case of negative confidence intervals, lower confidence limits are not shown. For clarity, data are shown as data of 10 (logarithmic scale)
Fig. 2
Fig. 2
Immune cell infiltration in relation to animal stroke model at days 1–7 after induction of ischemia. Flow cytometric analysis of the ipsilateral brain hemisphere (a) and histological analysis (b infarct core, c penumbra) showing the absolute numbers of infiltrating immune cells (macrophages, neutrophils, and T cells) in the ischemic hemisphere for each type of ischemia: distal permanent (bare triangle), proximal transient (bare circle), distal transient (bare square), and proximal permanent (bare rhombus). Meta-analyzed data are shown as mean with higher and lower 95% confidence interval (red). In case of negative confidence intervals, lower confidence limits are not shown
Fig. 3
Fig. 3
Meta-regression analysis of the association between immune cell density of macrophages/microglia, neutrophils, or T cells and infarct volume 1–42 days after induction of ischemia. Due to the significant difference in infarct size, values for mice (a) and rats (b) are calculated separately. Values represent numbers of immune cells/mm3 in the infarct core and infarct volume in mm3
Fig. 4
Fig. 4
Schematics of temporal profile of immune cell infiltration in rodent (a, b, c) and human (b) stroke. Curves are created from data obtained from this study. In rodent stroke, numbers of immune cells are graphically calculated from the original data of histological (cells/mm3; a, b) and of FACS analysis (cells per ischemic hemisphere; c)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612–1623. doi: 10.1016/S0140-6736(08)60694-7. - DOI - PubMed
    1. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006–1018. doi: 10.1016/S1474-4422(09)70236-4. - DOI - PubMed
    1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–99. - PubMed
    1. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796–808. doi: 10.1038/nm.2399. - DOI - PMC - PubMed
    1. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181–198. doi: 10.1016/j.neuron.2010.07.002. - DOI - PMC - PubMed

Publication types